Science ❯ Biotechnology ❯ mRNA Technology

Vaccine Development

COVID-19 Vaccines Public Health Cancer Vaccines Curevac Clinical Trials Influenza Vaccines Infectious Diseases Moderna's mRNA RSV Vaccine Moderna's Combined Vaccine Immune Response Clinical Research Public Health Applications Influenza Vaccine Development Clinical Applications RSV Vaccine CureVac

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

The agency said the Phase 3 control for seniors did not reflect the U.S. best standard of care, a rare procedural rebuke that Moderna disputes.

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

US Cuts $500 Million in mRNA Vaccine Research Funding

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial